
Sign up to save your podcasts
Or


In this episode of PROSTATE CANCER: REAL TALK, hosts El and Shay welcome Dr. Natalie Reizine, a physician and researcher in Hematology and Oncology at UI Health and the University of Illinois Cancer Center. Dr. Reizine specializes in treating genital and urinary cancers, with a focus on personalized treatments for prostate, kidney, bladder, and germ cell tumors.
Together, they explore the potential of glycyrrhizin, an active compound found in licorice root, to aid in fighting prostate cancer. Dr. Reizine provides her expertise on how genes impact treatment responses and how to maximize therapeutic benefits while minimizing treatment toxicity.
El shares how he met Dr. Reizine in his role as a paid external advisory board member for UIC’s Cures Within Reach Focus Group, which is dedicated to engaging underserved patients through clinical research trials.
Tune in to learn about the fascinating potential of glycyrrhizin and how it might become part of a more personalized approach to prostate cancer treatment.
www.prostatecancerrealtalk.com
By Elverage5
22 ratings
In this episode of PROSTATE CANCER: REAL TALK, hosts El and Shay welcome Dr. Natalie Reizine, a physician and researcher in Hematology and Oncology at UI Health and the University of Illinois Cancer Center. Dr. Reizine specializes in treating genital and urinary cancers, with a focus on personalized treatments for prostate, kidney, bladder, and germ cell tumors.
Together, they explore the potential of glycyrrhizin, an active compound found in licorice root, to aid in fighting prostate cancer. Dr. Reizine provides her expertise on how genes impact treatment responses and how to maximize therapeutic benefits while minimizing treatment toxicity.
El shares how he met Dr. Reizine in his role as a paid external advisory board member for UIC’s Cures Within Reach Focus Group, which is dedicated to engaging underserved patients through clinical research trials.
Tune in to learn about the fascinating potential of glycyrrhizin and how it might become part of a more personalized approach to prostate cancer treatment.
www.prostatecancerrealtalk.com

32,062 Listeners

137 Listeners

11,908 Listeners

3 Listeners

3,474 Listeners

112,351 Listeners

14 Listeners

26 Listeners

14,343 Listeners

20,434 Listeners

1,651 Listeners

12 Listeners